Vaxdyn, S. L.
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $13M
Investors
- 3
About Vaxdyn, S. L.
L. is a biotechnology company Co-founded in 2011 by Michael J. McConnell & Pilar Perez Romero. Dr. Juan José Infante serves as the company's Chief Executive Officer. The company develops vaccines targeting bacterial infections, including AcinetoVax for Acinetobacter baumannii and KapaVax for Pseudomonas aeruginosa and Klebsiella pneumoniae. In September 2026, Vaxdyn, S. L. Vaxdyn develops vaccines targeting antibiotic-resistant infections, including AcinetoVax, aimed at Acinetobacter baumannii, and KapaVax, which targets Pseudomonas aeruginosa and Klebsiella pneumoniae. These products address critical healthcare needs globally, focusing on regions severely impacted by antibiotic resistance.
Who invested in Vaxdyn, S. L.
3 investors across 2 rounds
See all investors in Vaxdyn, S. L.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vaxdyn, S. L.
Who invested in Vaxdyn, S. L.?
Vaxdyn, S. L. has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vaxdyn, S. L. raised?
Vaxdyn, S. L. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Vaxdyn, S. L. last raise money?
Vaxdyn, S. L.'s most recent round on record is a Series A, in Sep 2026.
What does Vaxdyn, S. L. do?
Vaxdyn, S. L. is a pharmaceuticals company.
Where is Vaxdyn, S. L. headquartered?
Vaxdyn, S. L. is headquartered in Sevilla, Spain.
Which VCs invest in companies like Vaxdyn, S. L.?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Vaxdyn, S. L.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Vaxdyn, S. L.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.